COVID: Spallanzani to start double Sputnik V experimentation

(ANSA) – ROME, MAR 26 – Rome’s Spallanzani
infectious-diseases hospital will start experimentation on the
Sputnik V COVID-19 vaccine in collaboration with Russia’s
Gamaleya Institute after Easter, sources said Friday.
    The research will go in two directions, the sources said.
    One line of experimentation will focus on the effectiveness of
Sputnik V against new COVID strains, especially the Brazilian,
South African and British variants, the sources said.
    The other will look at the giving Sputnik V as a second dose on
people who have had the first doses of a vaccine with a similar
structure, such as the AstraZeneca one, the sources said.
    The Gamaleya Institute will provide 100 doses for the first
phase of testing. (ANSA).
   

Previous

Mother and ex get life for killing 20-mt-old boy

Cop talks woman out of suicide over the phone

Next

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close